Cargando…
Paraneoplastic neuronal intermediate filament autoimmunity
OBJECTIVE: To describe paraneoplastic neuronal intermediate filament (NIF) autoimmunity. METHODS: Archived patient and control serum and CSF specimens were evaluated by tissue-based indirect immunofluorescence assay (IFA). Autoantigens were identified by Western blot and mass spectrometry. NIF speci...
Autores principales: | Basal, Eati, Zalewski, Nicholas, Kryzer, Thomas J., Hinson, Shannon R., Guo, Yong, Dubey, Divyanshu, Benarroch, Eduardo E., Lucchinetti, Claudia F., Pittock, Sean J., Lennon, Vanda A., McKeon, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207411/ https://www.ncbi.nlm.nih.gov/pubmed/30282771 http://dx.doi.org/10.1212/WNL.0000000000006435 |
Ejemplares similares
-
Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019) -
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
por: McKeon, Andrew, et al.
Publicado: (2020) -
Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders
por: Hinson, Shannon R., et al.
Publicado: (2018) -
Neurochondrin neurological autoimmunity
por: Shelly, Shahar, et al.
Publicado: (2019) -
Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)